MindMed
phase study results key phase study results support progression of results from phase progression of clinical trial demonstrate tolerability and support linear maintained across the tested doses and clinical effects align with potent regimen suitable regimen in withdrawal aligns with preclinical evidence offers potential to be a more frequencies engagement | MindMed
Company
Deck Type
Sector
Industry
Deck date
June 2023
Slide
26 of 36
Similar slides by MindMed
See diffirences between slides (animation)
Results
May 2022
phase study results key phase study results support progression of into planned upcoming phase clinical program well tolerated up to per day in single ascending dose sad and per day in the multiple ascending dose mad linear maintained across the tested doses and frequencies clinical effects align with potent engagement regimen aligns with preclinical evidence offers potential to be a more effective regimen in withdrawal | MindMed
Related slides by other companies
Albireo Pharma
Results
October 2022
assert phase results summary | Albireo Pharma
Alkermes
Investor Conference
January 2022
first in human study underway and clinical strategy focused on early validation of biology | Alkermes
NeuroSense Therapeutics
Investor Presentation
December 2023
milestones achieved and upcoming potential catalysts | NeuroSense Therapeutics
DICE Therapeutics
Investor Presentation
March 2023
key from phase efficacy results dice | DICE Therapeutics
Other recent decks by MindMed
See all presentations (7 decks)
Results
November 2023
Investor Presentation
September 2023
Investor Presentation
August 2023
Investor Day
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io